(S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
Enalaprilat (anhydrous) is enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor and an antihypertensive agent. It is a dicarboxylic acid and a dipeptide.
Source: ChEBIDisclaimer: The information above is provided for general reference purposes only. Applications, dosage, handling procedures and suitability for any specific use must be determined solely by the user based on their own assessment. This information does not constitute a recommendation or endorsement for any particular application and should not be used as the basis for product selection.
| Catalog No. | 76420729 |
|---|---|
| CAS Number | 76420-72-9 |
| IUPAC Name | (2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| Purity | 98% |
| SMILES | O=C([C@H]1N(CCC1)C([C@@H](N[C@@H](CCC2=CC=CC=C2)C(O)=O)C)=O)O |
Certificate of Analysis (COA)
Batch-specific analytical results confirming purity, identity, and quality.
Safety Data Sheet (SDS)
GHS-compliant safety information including hazards, handling, and disposal.
This product is not classified as a hazardous material under standard shipping regulations.
For complete safety information, always refer to the product's Safety Data Sheet.